Purchase Order SPE2DP25P0351

Award Date 4/29/25
Potential Completion Date 5/14/25
Potential Value $1.5K
Federal Agency
Medical Supply Chain
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Competed under SAP
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Lake Zurich, IL, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
4
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, valued at $1,014.52, was issued by the Defense Logistics Agency (DLA) to Fenwal, Inc., a global blood technology company and subsidiary of Fresenius Kabi. The contract is for the delivery of a DILUTING SOLUTION,F product, which is likely a specialized medical supply or consumable used in healthcare or biomedical research applications. The contract is a firm fixed-price purchase order with no set-aside designation, indicating Fenwal's competitive capabilities in the...
This federal contract award, valued at $3,297.19, was issued by the Defense Logistics Agency (DLA) to Fenwal, Inc., a global blood technology company and subsidiary of Fresenius Kabi. The contract is for the delivery of a Diluting Solution, which is a specialized medical supply that supports healthcare and biomedical research initiatives. The contract is a firm fixed-price purchase order without a set-aside designation, indicating Fenwal's competitive capabilities in the federal procurement...
This federal contract award, valued at $1,975.92, was issued by the Defense Logistics Agency Troop Support Medical to Fenwal, Inc., a global blood technology company and subsidiary of Fresenius Kabi. The contract is for the supply of 8510072100 - DILUTING SOLUTION,F, a medical supply item. The contract has a period of performance through August 31, 2023 and is a firm fixed-price purchase order. Fenwal, Inc. is a registered vendor with the U.S. federal government, providing a wide range of...
This is a firm fixed-price purchase order contract awarded by the Defense Logistics Agency (DLA) to Fenwal, Inc., a foreign-owned, for-profit manufacturer of medical equipment and supplies located in Lake Zurich, Illinois. The contract is for the supply of diluting solution, a specialized medical product, with a ceiling value of $1,139.76 and a period of performance ending on May 5, 2025. The contract was awarded on April 29, 2025, and does not have a set-aside designation. Fenwal, Inc. is a...
This firm-fixed-price purchase order was awarded by the Defense Logistics Agency Troop Support Medical, a component of the Department of Defense, to Fenwal, Inc., a global blood technology company and subsidiary of Fresenius Kabi. The $7,243.20 contract is for the delivery of a diluting solution product, identified by the NSN 8510518241. The award does not have a set-aside designation. Fenwal has been a registered vendor with the U.S. federal government since 2007 and has a history of...
This is a firm fixed-price purchase order awarded by the Defense Logistics Agency (DLA) to Fenwal, Inc., a foreign-owned, for-profit manufacturer of specialized medical equipment and consumables. The contract, valued at $1,519.68, is for the supply of a diluting solution (NSN: 8511339637). The award does not have a set-aside designation. Fenwal, Inc. is a critical supplier to various federal agencies, providing products that support healthcare and biomedical research initiatives, including...
This firm fixed-price purchase order (SPE2DP20V0090) was awarded by the Defense Logistics Agency (DLA) to Fenwal, Inc., a foreign-owned, for-profit manufacturer of specialized medical equipment and consumables. The $1,081.44 contract is for the supply of a diluting solution (8506977469) and does not have a set-aside designation. Fenwal, Inc. is a critical supplier to various federal agencies, providing products that support healthcare and biomedical research initiatives, including military...
This is a firm fixed-price purchase order contract awarded by the Defense Logistics Agency (DLA), a component of the Department of Defense, to Fenwal, Inc., a global blood technology company and subsidiary of Fresenius Kabi. The contract is for the provision of washing solution, which is a specialized medical product used in healthcare and biomedical research applications. The contract has a ceiling value of $11,351.91 and an ultimate completion date of October 17, 2023. Fenwal, Inc. is a...
This federal contract award, valued at $2,570.40, was issued by the Defense Logistics Agency (DLA) to Fenwal, Inc., a global blood technology company and subsidiary of Fresenius Kabi located in Lake Zurich, Illinois. The contract is a firm fixed-price purchase order for the supply of specialized medical products, such as blood collection assemblies, washing solutions, and apheresis equipment, to support critical healthcare programs, including military medical supply chains, biomedical research...
This federal contract award, with ID SPE2DP23P0467, was issued by the Defense Logistics Agency (DLA) to Fenwal, Inc., a global blood technology company and subsidiary of Fresenius Kabi located in Lake Zurich, Illinois. The $3,510.90 firm fixed-price purchase order is for the supply of washing solution, a specialized medical product used in healthcare and biomedical research initiatives. The contract has no set-aside designation and supports critical defense medical supply chains. Fenwal, Inc. is...

This is a firm fixed-price purchase order awarded by the Defense Logistics Agency (DLA) to Fenwal, Inc., a global blood technology company and subsidiary of Fresenius Kabi located in Lake Zurich, Illinois. The contract is for the supply of diluting solution (CLIN 8511340171) with a ceiling value of $1,519.68 and a period of performance ending on May 14, 2025. Fenwal, Inc. is a registered vendor with the U.S. federal government, specializing in the manufacture of blood collection, separation, storage, and transfusion products and services. This contract award supports critical healthcare programs, including military medical supply chains, biomedical research initiatives, and blood banking operations. The contract was not set aside for any specific small business category.

Generated 7/29/25, 9:48 AM